Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-025484 General Corporate
Debt relative to revenue 93th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
104.92% · OPTIONAL · VALID
Capex intensity 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.27% · OPTIONAL · VALID
Operating cash generation 86th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.22% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
12.98% · CORE · VALID
Inventory pressure 43th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
104.15% · OPTIONAL · VALID
Gross margin 36th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
23.89% · CORE · VALID
Operating margin 50th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
4.65% · CORE · VALID
R&D intensity 43th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.77% · OPTIONAL · VALID
SBC intensity 69th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.48% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 105.63%
Current 104.92%
Delta -0.72% Capex Intensity Increased
Previous 1.76%
Current 2.27%
Delta 0.50% Cash Generation Increased
Previous 6.64%
Current 12.22%
Delta 5.58% Growth Decreased
Previous 21.03%
Current 12.98%
Delta -8.06% Inventory Pressure Increased
Previous 94.30%
Current 104.15%
Delta 9.85% Margin Decreased
Previous 25.12%
Current 23.89%
Delta -1.23% Profitability Decreased
Previous 6.70%
Current 4.65%
Delta -2.05% R And D Intensity Increased
Previous 4.74%
Current 4.77%
Delta 0.04% Sbc Intensity Increased
Previous 0.45%
Current 0.48%
Delta 0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.